SUPN
SUPERNUS PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$42.00
−2.14%Forward multiples
Based on analyst estimates
- P/E forward
- 14.53x
- P/E 2026E
- 16.28x
- P/E 2027E
- 9.36x
- P/E 2028E
- 7.73x
- P/S forward
- 2.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.37x
- Price / sales
- 2.94x
- Price / cash flow
- 122.82x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- 2.55x
- EV / EBITDA
- -133.19x
- EV / EBIT
- -18.90x
- Market cap
- $2.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026